Amylyx Pharmaceuticals Inc’s recently made public that its Co-Chief Executive Officer Klee Justin B. unloaded Company’s shares for reported $77440.0 on Mar 05 ’24. In the deal valued at $18.73 per share,4,135 shares were sold. As a result of this transaction, Klee Justin B. now holds 2,959,308 shares worth roughly $7.9 million.
Then, Cohen Joshua B sold 4,135 shares, generating $77,440 in total proceeds. Upon selling the shares at $18.73, the Co-Chief Executive Officer now owns 3,023,002 shares.
Before that, FRATES JAMES M sold 1,792 shares. Amylyx Pharmaceuticals Inc shares valued at $33,560 were divested by the Chief Financial Officer at a price of $18.73 per share. As a result of the transaction, FRATES JAMES M now holds 134,784 shares, worth roughly $0.36 million.
Mizuho downgraded its Amylyx Pharmaceuticals Inc [AMLX] rating to a Neutral from a a Buy in a research note published on March 18, 2024; the price target was decreased to $4 from $32. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who decreased its forecast for the stock in mid March from “an Outperform” to “a Neutral”. Leerink Partners also remained covering AMLX and has decreased its forecast on March 11, 2024 with a “Market perform” recommendation from previously “an Outperform” rating. Goldman revised its rating on March 08, 2024. It rated AMLX as “a Neutral” which previously was an “a Buy”.
Price Performance Review of AMLX
On Tuesday, Amylyx Pharmaceuticals Inc [NASDAQ:AMLX] saw its stock fall -0.74% to $2.67. Over the last five days, the stock has gained 1.91%. Amylyx Pharmaceuticals Inc shares have fallen nearly -81.86% since the year began. Nevertheless, the stocks have fallen -90.81% over the past one year. While a 52-week high of $31.77 was reached on 02/29/24, a 52-week low of $2.52 was recorded on 04/02/24. SMA at 50 days reached $10.71, while 200 days put it at $16.23. A total of 1.95 million shares were traded, compared to the trading of 2.83 million shares in the previous session.
Levels Of Support And Resistance For AMLX Stock
The 24-hour chart illustrates a support level at 2.59, which if violated will result in even more drops to 2.50. On the upside, there is a resistance level at 2.79. A further resistance level may holdings at 2.90. The Relative Strength Index (RSI) on the 14-day chart is 21.87, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.08, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 70.59%. Stochastics %K at 26.21% indicates the stock is a holding.
How much short interest is there in Amylyx Pharmaceuticals Inc?
A steep rise in short interest was recorded in Amylyx Pharmaceuticals Inc stocks on Mar 15, 2024, growing by 0.11 million shares to a total of 5.09 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 4.98 million shares. There was a rise of 2.16%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 10.01% of the overall stock float, the days-to-cover ratio (short ratio) rose to 0.84.
